找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Handbook of Cystic Fibrosis; Amy G. Filbrun,Thomas Lahiri,Clement L Ren Book 2016 Springer International Publishing Switzerland 2016 CFTR

[復(fù)制鏈接]
樓主: EVOKE
21#
發(fā)表于 2025-3-25 06:08:02 | 只看該作者
The Rise of Effective Treatments, of CF care has become even brighter with the development of CFTR modulators; medications that can target the underlying defect causing CF. Currently available CFTR modulators target only a small proportion of patients with CF or lack potency, although, newer more effective compounds are under devel
22#
發(fā)表于 2025-3-25 11:23:44 | 只看該作者
23#
發(fā)表于 2025-3-25 14:45:05 | 只看該作者
,Uniqueness of meromorphic functions on ?,tic fibrosis transmembrane conductance regulator (CFTR) modulator therapies heralds a new era in CF care, their full impact on CF remains to be determined, and older patients with CF are likely to still have complications of CF that need to be addressed.
24#
發(fā)表于 2025-3-25 17:42:00 | 只看該作者
25#
發(fā)表于 2025-3-25 22:20:02 | 只看該作者
26#
發(fā)表于 2025-3-26 02:14:12 | 只看該作者
Bernhard Kramann,Manfred SchmelingCystic fibrosis (CF) is a multisystem disease, and its clinical features reflect the broad impact that loss of cystic fibrosis transmembrane conductance regulator (CFTR) function has on multiple organs (Fig. .). However, pulmonary and gastrointestinal disease account for the vast majority of morbidity and mortality in CF.
27#
發(fā)表于 2025-3-26 07:35:15 | 只看該作者
Clinical Features and Complications of Cystic Fibrosis,Cystic fibrosis (CF) is a multisystem disease, and its clinical features reflect the broad impact that loss of cystic fibrosis transmembrane conductance regulator (CFTR) function has on multiple organs (Fig. .). However, pulmonary and gastrointestinal disease account for the vast majority of morbidity and mortality in CF.
28#
發(fā)表于 2025-3-26 12:23:36 | 只看該作者
Amy G. Filbrun,Thomas Lahiri,Clement L RenConcise yet complete overview of the epidemiology, pathophysiology, and clinical features of cystic fibrosis and an in-depth review of the most up-to-date methods of diagnosis, symptom management, and
29#
發(fā)表于 2025-3-26 12:56:43 | 只看該作者
http://image.papertrans.cn/h/image/421123.jpg
30#
發(fā)表于 2025-3-26 20:41:00 | 只看該作者
https://doi.org/10.1007/978-3-319-32504-0CFTR mutations; Cystic Fibrosis; Cystic Fibrosis manifestations; Pulmonary; Respiratory medicine
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-17 03:13
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
鲁山县| 安康市| 赞皇县| 遂溪县| 镇雄县| 秭归县| 上高县| 弋阳县| 黄骅市| 乐至县| 浦江县| 江油市| 昌图县| 申扎县| 平原县| 阿合奇县| 尤溪县| 武功县| 朔州市| 惠州市| 宁河县| 方城县| 曲麻莱县| 博爱县| 红桥区| 南澳县| 武城县| 海口市| 沅陵县| 桐梓县| 迁安市| 页游| 宿松县| 海安县| 武冈市| 潼关县| 财经| 寿阳县| 清流县| 南平市| 齐河县|